Kathryn Defea
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$894KFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $894K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 15, 2023 | NIH | STTR Phase I Development of small molecule Protease-activated-receptor-2 antagonists as oral asthma therapeutics | $300K | PARMEDICS, INC with UNIVERSITY OF ARIZONA |
| Jan 15, 2023 | NIH | STTR Phase I Protease-activated-receptor-2 antagonists for treatment of migraine pain | $310K | PARMEDICS, INC with UNIVERSITY OF TEXAS DALLAS |
| Sep 1, 2021 | NIH | STTR Phase I Development of Small Molecule Antagonists of PAR-2 for treatment of asthma | $283K | PARMEDICS, INC with UNIVERSITY OF ARIZONA |
1 patents as inventor
- US PARMEDICS, INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,888
Awards as PI#822
Patents#273
Companies
- PARMEDICS, INCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.